TearScience Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:TearScience Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10331
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TearScience Inc (TearScience) is a medical device company that carries out identifying, diagnosing, and treating meibomian gland dysfunction (MGD). The company conducts early detection and treatment of prevalent, chronic, and progressive MGD. It offers LipiFlow thermal pulsation system, a single-use sterile device that delivers automated therapeutic energies to meibomian gland while protecting the delicate structures of the patient’s eye. TearScience also develops LipiScan, a gland imager that allows eye care professionals to evaluate meibomian glands in practices; and LipiView II, an ocular surface interferometer with dynamic meibomian imaging measures lipid layer thickness with nanometer accuracy. The company markets its products across Canada, Australia, New Zealand, the US, and others. TearScience is headquartered in Morrisville, North Carolina, the US.

TearScience Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearScience Inc, Medical Equipment, Deal Details 10
Venture Financing 10
TearScience Raises Funds through Series D Financing 10
TearScience Raises Up To US$70 Million In Venture Financing 11
Equity Offering 12
TearScience, Developer of Medical Devices, Plans For IPO 12
Asset Transactions 13
Shinagawa Lasik Acquires TearScience Dry Eye System From TearScience 13
Acquisition 14
Abbott Medical Optics Acquires TearScience 14
TearScience Inc – Key Competitors 15
TearScience Inc – Key Employees 16
TearScience Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
TearScience Inc, Medical Equipment, Key Facts 2
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Deals By Market, 2012 to YTD 2018 8
TearScience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
TearScience Raises Funds through Series D Financing 10
TearScience Raises Up To US$70 Million In Venture Financing 11
TearScience, Developer of Medical Devices, Plans For IPO 12
Shinagawa Lasik Acquires TearScience Dry Eye System From TearScience 13
Abbott Medical Optics Acquires TearScience 14
TearScience Inc, Key Competitors 15
TearScience Inc, Key Employees 16

List of Figures
TearScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
TearScience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
TearScience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
TearScience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
TearScience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[TearScience Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sumitomo Realty & Development Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Realty & Development Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Culture Landmark Investment Ltd
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nordson Corporation:企業の戦略・SWOT・財務分析
    Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Andhra Pradesh Power Generation Corporation Ltd-エネルギー分野:企業M&A・提携分析
    Summary Andhra Pradesh Power Generation Corporation Limited (APGENCO) is a state-owned electricity utility that that conducts the generation, operation, maintenance and execution of energy projects. The company owns, operates, and maintains thermal, hydel and wind power plants. APGENCO also undertak …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • PKO Bank Polski SA:企業の戦略・SWOT・財務情報
    PKO Bank Polski SA - Strategy, SWOT and Corporate Finance Report Summary PKO Bank Polski SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Otto GmbH & Co KG:企業の戦略・SWOT・財務情報
    Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report Summary Otto GmbH & Co KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wienerberger AG:企業のM&A・事業提携・投資動向
    Wienerberger AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Wienerberger AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Butler National Corporation:企業の戦略・SWOT・財務情報
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Permasteelisa S.p.A.:企業の戦略・SWOT・財務情報
    Permasteelisa S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Permasteelisa S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Protagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Protagen AG (Protagen) is a medical device company that develops molecular diagnostic and companion diagnostic test equipment. The company’s products include multilisa Ssc, multilisa SLE and multilisa RA. It provides products for autoimmune diseases such as rheumatoid arthritis, neuromyeliti …
  • MannKind Corp (MNKD)-製薬・医療分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …
  • Avantium NV (AVTX):企業の財務・戦略的SWOT分析
    Avantium NV (AVTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • BaroFold Inc-製薬・医療分野:企業M&A・提携分析
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein refolding services. The company offers services such as research study services, optimization study services, and process implementation services. Its optimization study services include confirm analytical services, res …
  • Galderma SA:医療機器:M&Aディール及び事業提携情報
    Summary Galderma SA (Galderma), a subsidiary of Nestle SA, is a pharmaceutical company that develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions s …
  • Samsung Engineering Co Ltd (028050):企業の財務・戦略的SWOT分析
    Samsung Engineering Co Ltd (028050) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • The Gap, Inc.:企業の戦略・SWOT・財務情報
    The Gap, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Gap, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pavmed Inc (PAVM):医療機器:M&Aディール及び事業提携情報
    Summary Pavmed Inc (Pavmed) is a medical device company. The company offers disposable infusion pumps, short-term catheters, percutaneous and tissue ablation devices, and long-term vascular access devices. Its products pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; P …
  • Anagin Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Anagin Inc (Anagin) formerly Anagin LLC, is a biotechnology company which develops novel targeted therapies for the treatment of neuropsychiatric diseases. The company is focused on the development of first-in-class small molecule modulators of neurotransmitter signaling complexes that reduc …
  • Juniper Networks Inc (JNPR):企業の財務・戦略的SWOT分析
    Juniper Networks Inc (JNPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆